Hepatic lipase and HDL metabolism

Current Opinion in Lipidology

Volumn 11, Issue 3, 2000, Pages 277-283

  Thuren, Tom ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID TRANSFER PROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; HYDROLYSIS; LIPOPROTEIN METABOLISM; LIVER CELL; PRIORITY JOURNAL; REVIEW; RISK; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARTERIOSCLEROSIS; CELLS, CULTURED; HUMANS; LIPASE; LIPOPROTEINS, HDL; LIVER; SUBSTRATE SPECIFICITY;

ANIMALIA;

EID: 0034128132     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200006000-00008     Document Type: Review

References (58)

1. 1 Stanhke G, Sprengel R, Augustin J, Will H. Human triglyceride lipase: cDNA cloning, amino acid sequence and expression in a cultured cell line. Differentiation 1987; 35:45-52.
2. 2 Datta S, Luo CC, Li WH, VanTuinen P, Ledbettrer DH, Brown MA, et al. Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem 1988; 263:1107-1110.
3. 3 Kuusi T, Nikkila EA, Virtanen I, Kinnunen PK. Localization of the heparin-releasable lipase in situ in the rat liver. Biochem J 1979; 181:245-246.
4. 4 Sanan DA, Fan J, Bensadoun A, Taylor JM. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res 1997; 38:1002-1013.
5. 5 Waite M. Phospholipases. In: Handbook of lipid research, vol 5. Hanahan D (editor). New York: Plenum Press; 1987. pp. 92-98.
6. 6 Waite M, Thuren T, Wilcox R, et al. Purification and substrate specificity of rat hepatic lipase. Methods Enzymol 1991; 197:331-339.
7. 7 Kinnunen PKJ. Lipases. Hepatic lipase. Borgstrom B, Brockman HL (editors). Amsterdam: Elsevier Science Publishers B.V.; 1984. pp. 307-328.
8. 8 Kounnas MZ, Chappell DA, Wong H, Argraves WS, Strickland DK. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteyglycans. J Biol Chem 1995; 270:9307-9312.
9. 9 Medh JD, Bowen SL, Fry GL, Ruben S, Hill J, Wong H, Chappell DA. Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoprotein in vitro. J Lipid Res 1999; 40:1263-1275. This is a very good study showing that hepatic lipase enhances VLDL degradation via LDL receptor pathway by concentrating VLDL particles onto cell surface prior to receptor interaction. One of a few studies showing that hepatic lipase binds to LDL receptor and enhances VLDL catabolism.
10. 10 Lambert G, Chase MB, Dugi K, Bensadoun A, Brewer HB, Santamarina-Fojo S. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J Lipid Res 1999; 40:1294-1303. One of many papers from this excellent group showing that hepatic lipase and scavenger receptor SR-B1 expression in kidney cells results in selective uptake of HDL cholesterol esters. This paper shows that inactive mutant hepatic lipase also enhances direct HDL cholesterol ester uptake.
11. 11 Verger R. Interfacial enzyme kinetics of lipolysis. Ann Rev Biophys Bioeng 1976; 5:77-117.
12. 12 Kinnunen PKJ, Enholm C. Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase. FEBS Lett 1976; 65:354-357.
13. 13 Shinomiya M, Sasaki N, Barnhart RL, Shirai K, Jackson RL. Effect of apolipoproteins on the hepatic lipase-catalyzed hydrolysis of human plasma high density lipoprotein2-triacylglycerols. Biochim Biophys Acta 1982; 713:292-299.
14. 14 Kubo M, Matsuzawa Y, Yokoyama S, Tajima S, Ishikawa K, Yamamoto A, Tarui S. Mechanism of inhibition of hepatic triglyceride lipase from human postheparin plasma by apolipoproteins A-I and A-II. J Biochem 1982; 92:865-870.
15. 15 Landis BA, Rotolo FS, Myers WC, Clark AB, Quarfordt SH. Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase. Am J Physiol 1987; 252:G805-G810.
16. 16 Jahn CE, Osborne JC, Schaefer EJ, Brewer BH. In vitro activation of the enzymic activity of hepatic lipase by apoA-II. FEBS Lett 1981; 131:366-368.
17. 17 Thuren T, Sisson P, Waite M. Activation of hepatic lipase catalyzed phosphatidylcholine hydrolysis by apolipoprotein E. Biochim Biophys Acta 1991; 1083:217-220.
18. 18 Kucera GL, Sisson PJ, Thomas MJ, Waite M. On the substrate specificity of rat liver phospholipase A1. J Biol Chem 1988; 263:1920-1928.
19. 19 Thuren T, Wilcox RW, Sisson P, Waite M. Hepatic lipase hydrolysis of lipid monolayers. Regulation by apolipoproteins. J Biol Chem 1991; 266:4853-4861.
20. 20 Vainio P, Virtanen JA, Kinnunen PKJ, Voyta JC, Smith LC, Gotto AM, et al. Action of lipoprotein lipase on phospholipid monolayers. Activation by apolipoprotein C-II. Biochemistry 1983; 22:2270-2275.{11}
21. 21 Bamberger M, Lund-Katz S, Phillips MC, Rothblat GH. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry 1985; 24:3693-3701.
22. 22 Jansen H, Van Tol A, Hulsmann WL. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun 1980; 92:53-59.
23. 23 Thuren T, Weisgraber KH, Sisson P, Waite M. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry 1992; 31:2332-2338.
24. 24 Coffill CR, Ramsamy TA, Hutt DM, Schultz JR, Sparks DL. Diacylglycerol is the preferred substrate in high density lipoproteins for human hepatic lipase. J Lipid Res 1997; 38:2224-2231.
25. 25 Deckelbaum RJ, Ramakrishnan R, Eisenberg S, Olivecrona T, Bengtsson-Olivecrona G. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry 1992; 31:8544-8551.
26. 26 Rye K-A, Clay MA, Barter PJ. Remodelling og high density lipoproteins by plasma factors. Atherosclerosis 1999; 145:227-238. An excellent review on remodelling of HDL in plasma. It reviews also their own work on remodelling of large HDL particles into smaller HDL particles by hepatic lipase and cholesterol ester transfer protein.
27. 27 Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25:1017-1058.
28. 28 Tansey JT, Thuren T, Jerome WG, Grant K, Waite M. Hydrolysis of phosphatidylcholine by hepatic lipase in discoidal and spherical recombinant-high density lipoprotein. Biochemistry 1997; 36:12227-12234.
29. 29 Guendouzi K, Collet X, Perret B, Chap H, Barbaras R. Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HepG2). Biochemistry 1998; 37:14974-14980. This is the first study that shows that HDL remodelling by hepatic lipase modifies binding and internalization of triglyceride rich HDL into hepatoma cells. This paper suggests that liver uptake of remodelled remnant HDL occurs after hepatic lipase action. This may explain kinetic studies showing that apoHDL is taken up by the liver.
30. 30 Rinninger F, Mann WA, Kaiser T, Ahle S, Meyer N, Greten H. Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture. Atherosclerosis 1998; 141:273-285.
31. 31 Rinninger F, Brundert M, Jackle S, Galle PR, Busch C, Izbichi JR, et al. Selective uptake of high-density lipoprotein-associated cholesteryl esters by human hepatocytes in primary culture. Hepatology 1994; 19:1100-1114.
32. 32 Thuren T, King L, Temel R, Williams DL. Inhibition of rat hepatocyte direct selective HDL cholesterol uptake by hepatic lipase and scavenger receptor SR-B1 antibodies. Ciculation 1998; 98(Suppl):1-201.[abstract] This study was the first to demonstrate that blocking antibodies against hepatic lipase and scavenger receptor SR-B1 inhibit direct selective HDL cholesterol uptake by hepatocytes. It implies that SR-B1 has a role in metabolism of HDL cholesterol in the liver.
33. 33 Amar MJA, Dugi K, Haudenschild CC, Shamburek RD, Foger B, Chase M, et al. Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice. J Lipid Res 1998; 39:2150-2160. An excellent study showing that catalytically inactive hepatic lipase mutant in transgenic mice enhances selective uptake of cholesterol esters. Provides evidence that hepatic lipase may act as a ligand in an animal model. This action of hepatic lipase is independent of lipolysis.
34. 34 Acton SL, Rigotti A, Landschultz KT, Xu S, Hobbs HH, Kieger M. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 1996; 271:460-41.
35. 35 Steinberg D. A docking receptor for cholesterol esters. Science 1996; 271:518-520.
36. 36 Homanics GE, de Silva HV, Osada J, Zhang SH, Wong H, Borensztajn J, Maeda N, et al. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem 1995; 270:2974-2980.
37. 37 Busch SJ, Barnhardt RL, Martin GA, Fitzgerald MC, Yates MT, Mao SJ, et al. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem 1994; 269:16376-16382.
38. 38 Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM, et al. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA 1994; 91:8724-8728.
39. 39 Barbagallo CM, Fan J, Blanche PJ, Rizzo M, Taylor JM, Krauss RM. Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler Thromb Vasc Biol 1999; 19:625-632. A transgenic rabbit study showing that hepatic lipase and apolipoprotein E expression reduced diet induced elevation in plasma cholesterol, small VLDL, IDL and HDL cholesterol. Effects of hepatic lipase and apolipoprotein E were synergistic. This provides evidence on the role of hepatic lipase in HDL metabolism and supports in vitro evidence on the interaction of hepatic lipase and apolipoprotein E.
40. 40 Weng W, Brandenburg NA, Zhong SB, Halkias J, Wu L, Jiang XC, et al. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice. J Lipid Res 1999; 40:1064-1070. This is one of many excellent transgenic mice studies from this group. Double knockout mice, hepatic lipase and apolipoprotein A-II deficient had higher HDL cholesterol, increased HDL size and decreased HDL cholesterol ester fractional catabolic rate when compared to apolipoprotein A-II knockout mice. Apolipoprotein A-II knockout mice showed active HDL triglyceride lipolysis by hepatic lipase. These studies suggested that apolipoprotein A-II is a physiological inhibitor for hepatic lipase and suggests that HDL A-I only particles are metabolically more active than HDL A-I/A-II particles.
41. 41 Blades B, Vega GI, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 1993; 13:1227-1235.
42. 42 Applebaum-Bowden D, Haffner SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR, et al. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis 1985; 5:273-282.
43. 43 Kuusi T, Enholm C, Viikari J, Harkonen R, Vartianen E, Puska P, Taskinen M-R, et al. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo-and hyperalphalipoproteinemia. J Lipid Res 1989; 30:1117-1126.
44. 44 Jackson RL, Yates MT, McNerney CA, Kashyap ML. Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Hormone Metab Res 1990; 22:289-294.
45. 45 Kuusi T, Saarinen P, Nikkila EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Arteriosclerosis 1980; 36:589-593.
46. 46 Haffner SM, Kushwaha RS, Fostere DM, Applebaum-Bowden D, Hazzard WR. Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 1983; 32:413-420.
47. 47 Applebaum-Bowden D, Haffner SM, Hazzard WR. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol. Metabolism 1987; 36:949-952.
48. 48 Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by ApoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Artioscler Thromb 1994; 14:707-720.
49. 49 Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb 1996; 16:431-440.
50. 50 Thuren TY, Rudel LL, Brinton EA, Herrington DM. Effect of estrogen on hepatic lipase and HDL particle size in post menopausal women. Circulation 1998; 98(Suppl):1-452.[abstract] This study showed that lower hepatic lipase activity was associated with elevated levels of larger HDL particles and decreased levels of smaller HDL particles. It suggested that large HDL particles indeed are substrate particles for hepatic lipase and that hepatic lipase may be involved in conversion of larger HDL particles into smaller HDL particles.
51. 51 Tangney CC, Mosca L, Otvos J, Rosenson RS. Hormone replacement therapy in post-menopausal women increases HDL particle size. Circulation 1998; 98(Suppl):1-7.[abstract] This study also showed that estrogen induced lowering of hepatic lipase activity was associated with increasing HDL size supporting the role of hepatic lipase in catabolism of larger HDL particles.
52. 52 Cohen JC, Vega GL, Grundy SM. Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol 1999; 10:259-267. An excellent review of the evidence from genetic and metabolic studies in humans on the role of hepatic lipase in lipoprotein metabolism. The emphasis of the review is on genetic polymorphisms of hepatic lipase and the association of hepatic lipase and coronary heart disease.
53. 53 Hegele RA, Little JA, Vezina A, Maguire GF, Tu L, Wolever TS, et al. Hepatic lipase deficiency. Clinical, biochemical and molecular genetic characteristics. Arterioscler Thromb 1993; 13:720-728.
54. 54 Demant T, Carlson LA, Holmquist L, Karpe F, Nihlsson-Ehle P, Packard CJ, Shepherd J, et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988; 29:1603-1611.
55. 55 Carlson LA. Deficiency of hepatic lipase activity in post-heparin plasma in familiar hyperalphalipoproteinemia. Acta Med Scand 1986; 219:435-447.
56. 56 Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 1989; 9:319-325.
57. 57 Connelly PW, Maguire GF, Lee M, Little JA. Plasma lipoproteins in familiar hepatic lipase deficiency. Arteriosclerosis 1990; 10:40-48.
58. 58 Mezdou H, Jones R, Dengremont C, Castro G, Maeda N. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E deficient mice. J Biol Chem 1997; 272:13570-13575.